Meta-Analysis: Higher vs. Lower Doses of ACE Inhibitors, Angiotensin-2 Receptor Blockers and Beta-blockers in Heart Failure with Reduced Ejection Fraction
1 Mar, 2019 | 05:38h | UTC
Related Commentary on Twitter
Our meta-analysis on higher versus lower doses of medications for heart failure just came out in PLOS ONE. You might be surprised at the magnitude of benefits vs harms of getting to "target doses" -always start with low doses and only increase if tolerated https://t.co/wvtTDqjV60
— James McCormack (@medmyths) February 28, 2019